Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey Wiezorek. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey Wiezorek har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:KITE / Kite Pharma, Inc. SVP Clinical Development 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey Wiezorek. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey Wiezorek som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -38.500 0 -100,00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -14.850 0 -100,00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -11.550 0 -100,00 116,13 -1.341.302
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -5.031 0 -100,00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -11.069 0 -100,00 128,04 -1.417.275
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -29.167 0 -100,00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -28.833 0 -100,00 173,11 -4.991.281
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Common Stock
D - Sale to Issuer -11.150 0 -100,00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Common Stock
U - Other -14.674 11.150 -56,82 180,00 -2.641.320 2.007.000
2017-09-27 2017-09-25 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale -5.283 25.824 -16,98 179,66 -949.164 4.639.641
2017-09-27 2017-09-25 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 10.000 31.107 47,38
2017-07-06 2017-07-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -10.000 58.000 -14,71
2017-07-06 2017-07-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.201 21.071 -5,39 104,76 -125.817 2.207.398
2017-07-06 2017-07-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -8.799 22.272 -28,32 104,26 -917.384 2.322.079
2017-07-06 2017-07-03 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 10.000 31.071 47,46 6,89 68.900 214.079
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -18.000 68.000 -20,93
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -160 21.071 -0,75 79,83 -12.773 1.682.098
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -311 21.231 -1,44 78,97 -24.560 1.676.612
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -150 21.542 -0,69 76,98 -11.547 1.658.303
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -157 21.692 -0,72 75,82 -11.904 1.644.687
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -16.561 21.849 -43,12 75,00 -1.242.075 1.638.675
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -328 38.410 -0,85 72,36 -23.734 2.779.348
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -259 38.738 -0,66 71,24 -18.451 2.759.695
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -74 38.997 -0,19 68,92 -5.100 2.687.673
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 18.000 39.071 85,43 6,89 124.020 269.199
2017-02-06 2017-02-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 86.000 -1,71
2017-02-06 2017-02-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.500 20.695 -6,76 51,21 -76.820 1.059.861
2017-02-06 2017-02-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 22.195 7,25 6,89 10.335 152.924
2017-01-10 2017-01-06 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 87.500 -1,69
2017-01-10 2017-01-06 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.500 20.695 -6,76 50,00 -75.000 1.034.750
2017-01-10 2017-01-06 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 22.195 7,25 6,89 10.335 152.924
2016-12-27 2016-12-22 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 38.500 38.500
2016-12-27 2016-12-22 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 5.600 20.695 37,10
2016-12-22 2016-12-20 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale -716 15.095 -4,53 50,86 -36.416 767.732
2016-12-05 2016-12-01 4 KITE Kite Pharma, Inc.
Comon Stock
S - Sale X -207 15.811 -1,29 51,23 -10.605 809.998
2016-12-05 2016-12-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.293 16.018 -7,47 50,68 -65.529 811.792
2016-12-05 2016-12-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 17.311 9,49 6,89 10.335 119.273
2016-12-05 2016-11-10 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 89.000 -1,66
2016-11-14 2016-11-10 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 76.208 -1,93
2016-11-14 2016-11-10 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.500 15.811 -8,67 50,18 -75.270 793.396
2016-11-14 2016-11-10 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 17.311 9,49 6,89 10.335 119.273
2016-10-05 2016-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 77.708 -1,89
2016-10-05 2016-10-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -170 15.811 -1,06 55,51 -9.437 877.669
2016-10-05 2016-10-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.330 15.981 -7,68 54,72 -72.778 874.480
2016-10-05 2016-10-03 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 17.311 9,49 6,89 10.335 119.273
2016-09-02 2016-09-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 79.208 -1,86
2016-09-02 2016-09-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -262 15.811 -1,63 58,58 -15.348 926.208
2016-09-02 2016-09-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.238 16.073 -7,15 58,17 -72.014 934.966
2016-09-02 2016-09-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 17.311 9,49 6,89 10.335 119.273
2016-08-02 2016-08-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 80.708 -1,82
2016-08-02 2016-08-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -609 14.867 -3,94 57,24 -34.859 850.987
2016-08-02 2016-08-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -891 15.476 -5,44 56,66 -50.484 876.870
2016-08-02 2016-08-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 16.367 10,09 6,89 10.335 112.769
2016-07-05 2016-07-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 82.208 -1,79
2016-07-05 2016-07-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.500 14.867 -9,16 50,00 -75.007 743.423
2016-07-05 2016-07-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 16.367 10,09 6,89 10.335 112.769
2016-06-02 2016-06-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 83.708 -1,76
2016-06-02 2016-06-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -175 14.867 -1,16 51,90 -9.082 771.597
2016-06-02 2016-06-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.325 15.042 -8,10 51,22 -67.866 770.451
2016-06-02 2016-06-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 16.367 10,09 6,89 10.335 112.769
2016-06-02 2016-05-31 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.500 85.208 -1,73
2016-06-02 2016-05-31 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.500 14.867 -9,16 50,00 -75.000 743.350
2016-06-02 2016-05-31 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 1.500 16.367 10,09 6,89 10.335 112.769
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7.292 86.708 -7,76
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -1.708 14.292 -10,68
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -259 14.867 -1,71 47,82 -12.385 710.940
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -461 15.126 -2,96 46,49 -21.432 703.208
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.538 15.587 -8,98 45,32 -69.702 706.403
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -6.742 17.125 -28,25 44,56 -300.424 763.090
2016-03-17 2016-03-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 23.867 60,54 6,89 62.010 164.444
2016-02-18 2016-02-16 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 16.000 -36,00
2016-02-18 2016-02-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.388 13.742 -9,17 44,47 -61.724 611.107
2016-02-18 2016-02-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -7.612 15.130 -33,47 44,00 -334.928 665.720
2016-02-18 2016-02-16 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 22.742 65,49 6,89 62.010 156.692
2016-02-18 2015-11-30 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 94.000 -8,74
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -200 13.742 -1,43 57,75 -11.550 793.600
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -648 13.942 -4,44 57,11 -37.007 796.228
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.121 14.590 -7,14 55,98 -62.754 816.748
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -5.987 15.711 -27,59 55,17 -330.303 866.776
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -670 21.698 -3,00 53,87 -36.093 1.168.871
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -374 22.368 -1,64 52,60 -19.672 1.176.557
2016-01-19 2016-01-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 22.742 65,49 6,89 62.010 156.692
2015-12-21 2015-12-17 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 26.400 26.400
2015-12-21 2015-12-17 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 7.400 13.742 116,68
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 103.000 -8,04
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -491 6.342 -7,19 65,27 -32.048 413.942
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.488 6.833 -33,80 64,58 -225.255 441.275
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.285 10.321 -18,13 63,59 -145.303 656.312
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.736 12.606 -17,83 62,64 -171.383 789.640
2015-12-17 2015-12-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 15.342 141,91 6,89 62.010 105.706
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 112.000 -7,44
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -90 6.342 -1,40 80,20 -7.218 508.628
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -741 6.432 -10,33 79,25 -58.724 509.736
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.598 7.173 -39,06 78,55 -361.173 563.439
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.159 11.771 -15,50 77,65 -167.646 914.018
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.412 13.930 -9,20 76,43 -107.919 1.064.670
2015-11-18 2015-11-16 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 15.342 141,91 6,89 62.010 105.706
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 121.000 -6,92
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -465 6.342 -6,83 64,19 -29.848 407.093
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.007 6.807 -22,77 63,50 -127.444 432.244
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.702 8.814 -34,79 62,54 -294.063 551.228
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.375 13.516 -9,23 61,61 -84.714 832.721
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -451 14.891 -2,94 60,42 -27.249 899.714
2015-10-19 2015-10-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 15.342 141,91 6,89 62.010 105.706
2015-09-17 2015-09-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 130.000 -6,47
2015-09-17 2015-09-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.440 6.342 -41,18 64,69 -287.224 410.264
2015-09-17 2015-09-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.560 10.782 -29,72 63,99 -291.794 689.940
2015-09-17 2015-09-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 15.342 141,91 6,89 62.010 105.706
2015-08-19 2015-08-17 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 139.000 -6,08
2015-08-19 2015-08-17 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -671 5.218 -11,39 61,83 -41.488 322.629
2015-08-19 2015-08-17 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.918 5.889 -45,51 61,16 -300.785 360.171
2015-08-19 2015-08-17 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.411 10.807 -23,99 60,26 -205.547 651.230
2015-08-19 2015-08-17 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 14.218 172,48 6,89 62.010 97.962
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 148.000 -5,73
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -100 5.218 -1,88 73,42 -7.342 383.106
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.951 5.318 -42,63 72,65 -287.040 386.353
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.519 9.269 -27,52 71,55 -251.784 663.197
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.024 12.788 -7,41 70,92 -72.622 906.925
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -406 13.812 -2,86 70,12 -28.469 968.497
2015-07-20 2015-07-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 14.218 172,48 6,89 62.010 97.962
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 157.000 -5,42
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.095 5.218 -37,23 58,04 -179.634 302.853
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3.295 8.313 -28,39 56,88 -187.420 472.843
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.610 11.608 -18,36 55,93 -145.977 649.235
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 14.218 172,48 6,89 62.010 97.962
2015-06-17 2014-06-25 4 KITE Kite Pharma, Inc.
Common Stock
P - Purchase 4.000 5.218 328,41 17,00 68.000 88.706
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -9.000 166.000 -5,14
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -128 1.218 -9,51 52,21 -6.683 63.592
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1.528 1.346 -53,17 51,57 -78.799 69.413
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2.638 2.874 -47,86 50,49 -133.193 145.108
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4.706 5.512 -46,06 49,44 -232.665 272.513
2015-05-19 2015-05-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 9.000 10.218 738,92 6,89 62.010 70.402
2014-12-30 2014-12-24 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 16.100 16.100
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)